Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114896) titled 'The effect of remimazolam combined with propofol for general anesthesia on postoperative delirium after major abdominal surgery: A multicenter, prospective, double-blind, randomized controlled study' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangxi Medical University Cancer Hospital
Condition:
Abdominal tumors (including digestive, urinary, gynecological, etc.)
Intervention:
Propofol + Remimazolam Group:Intravenous injection of sufentanil 0.3-0.5 µg/kg (60s), followed by intravenous injection of propofol 1-2 mg/kg, followed by intravenous injection of ...